The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis

Jitka Holcakova1, Pavla Ceskova, Roman Hrstka

  • 1Department of Oncological and Experimental Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Insights

The p73 protein, a p53 family member, influences cancer therapy responses. Its various isoforms show differential DNA binding and transcriptional activity, impacting apoptosis and cell cycle arrest differently based on tumor cell type.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • p73, a p53 family member, shares growth arrest and apoptosis functions with p53.
  • p73 plays a role in chemotherapeutic responses in cancer patients, often in conjunction with p53.
  • Alternative splicing of the TP73 gene generates diverse p73 isoforms with varying transcriptional activities.

Purpose of the Study:

  • To investigate the functional differences among p73 C-terminal spliced isoforms.
  • To determine the relationship between DNA-binding capacity and transcriptional activity of p73 isoforms.
  • To elucidate the impact of p73 isoforms on apoptosis and cell cycle regulation in different cancer cell backgrounds.

Main Methods:

  • Analysis of DNA-binding capacity of p73 C-terminal isoforms.
  • Assessment of transcriptional activity on p53-responsive promoters.
  • Induction of apoptosis and cell cycle arrest studies in p53-null cell lines (H1299, Saos-2).
  • Gene expression profiling following p73 isoform induction.

Main Results:

  • p73 C-terminal isoforms exhibit distinct DNA-binding capabilities, not directly correlating with transcriptional activity.
  • p73beta induces apoptosis via mitochondrial or death receptor pathways, with corresponding gene expression changes in different cell lines.
  • p73 induces cell cycle arrest and p21(WAF1) expression in H1299 cells but not in Saos-2 cells.

Conclusions:

  • TAp73 isoforms display context-dependent activity influenced by the tumor cell genetic background.
  • The differential functions of p73 isoforms have significant implications for personalized cancer therapy strategies.
  • Understanding p73 isoform behavior is crucial for predicting and optimizing patient responses to chemotherapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.